Energy metabolism defects in Huntington's disease and effects of coenzyme Q10

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes

MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366

Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

Beal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 962

Mitochondrial defect in Huntington's disease caudate nucleus

Gu, M., Gash, M. T., Mann, V. M., Javoy‐Agid, F., Cooper, J. M., & Schapira, A. H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390317 · Cited by 758

Alternative excitotoxic hypotheses

Albin, R. L., & Greenamyre, J. T. (1992) · Neurology · doi:10.1212/wnl.42.4.733 · Cited by 574

Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates.

Brouillet, E., Hantraye, P., Ferrante, R. J., Dolan, R., Leroy‐Willig, A., Kowall, N. W., & Beal, M. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7105 · Cited by 485

Rapid enzymatic measurement of blood lactate and pyruvate. Use and significance of metaphosphoric acid as a common precipitant.

Marbach, E. P., & Weil, M. H. (1967) · PubMed · Cited by 480

Evidence for irnnairment of energy metabofism in vivo in Huntington's disease using localized 1H NMR spectroscopy

Jenkins, B. G., Koroshetz, W. J., Beal, M. F., & Rosen, B. R. (1993) · Neurology · doi:10.1212/wnl.43.12.2689 · Cited by 479

Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH

Burke, J. R., Enghild, J. J., Martin, M. E., Jou, Y., Myers, R., Roses, A. D., Vance, J. M., & Strittmatter, W. J. (1996) · Nature Medicine · doi:10.1038/nm0396-347 · Cited by 430

Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues

Strong, T. V., Tagle, D. A., Valdes, J. M., Elmer, L. W., Boehm, K., Swaroop, M., Kaatz, K. W., Collins, F. S., & Albin, R. L. (1993) · Nature Genetics · doi:10.1038/ng1193-259 · Cited by 417

Rapid Enzymatic Measurement of Blood Lactate and Pyruvate

Marbach, E. P., & Weil, M. H. (1967) · Clinical Chemistry · doi:10.1093/clinchem/13.4.314 · Cited by 396

Neuroprotective Potential of Creatine. Hidden Resources of Its Therapeutic and Preventive Use

Нерсесова, Л. С., Petrosyan, M. S., & Arutjunyan, A. V. (2022) · Neurochemical Journal · doi:10.1134/s1819712422010093 · Cited by 7

Maladies par expansion de polyglutamine : données moléculaires et physiopathologiques

Lèbre, A.-S., & Brice, A. (2001) · médecine/sciences · doi:10.1051/medsci/200117111149 · Cited by 6

Coenzyme Q10: Role in Less Common Age-Related Disorders

Mantle, D., & Hargreaves, I. P. (2022) · Antioxidants · doi:10.3390/antiox11112293 · Cited by 6

The effect of ubiquinone on functional recovery and morphometric indices of sciatic nerve regeneration.

Moradi, Z., Azizi, S., & Hobbenaghi, R. (2014) · PubMed Central · Cited by 6

Brain Oximetry and the Quest for Quantified Metabolic Rate: Applications Using MRI and Near-Infrared Spectroscopy

Hashem, M., & Dunn, J. F. (2021) · Applied Magnetic Resonance · doi:10.1007/s00723-021-01345-y · Cited by 6

The Use of the Mitochondrial Toxin 3-NP to Uncover Cellular Dysfunction in Huntington’s Disease

Hernández, E., la Rosa-Lpez, G. D., & Mendoza, E. (2012) · InTech eBooks · doi:10.5772/31284 · Cited by 6

Natural Products against Huntington's Disease ( HD ): Implications of Neurotoxic Animal Models and Transgenics in Preclinical Studies

Dey, A. (2017) · Wiley eBooks · doi:10.1002/9783527803781.ch8 · Cited by 6

Toxin Induced Mitochondrial Dysfunction and Neurodegeneration

Sabri, M. I. (1998) · Springer eBooks · doi:10.1007/978-3-662-12509-0_14 · Cited by 5

Role of Mitochondria in Neurodegenerative Diseases: The Dark Side of the “Energy Factory”

Correia, S. C., & Moreira, P. I. (2018) · Springer eBooks · doi:10.1007/978-3-319-73344-9_11 · Cited by 5

Inhibition of Mitochondrial Creatine Kinase Activity by D-2-Hydroxyglutaric Acid in Cerebellum of Young Rats

da Silva, C. G., Bueno, A. R. F., Rosa, R. B., Dutra‐Filho, C. S., Wannmacher, C. M. D., Wyse, Â. T. D. S., & Wajner, M. (2003) · Neurochemical Research · doi:10.1023/a:1024936129908 · Cited by 5

Huntington Disease

Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50018-8 · Cited by 5

Workshop II: “Neuroprotection”– the Lugano consensus

Riederer, P. F., Brücke, T., Müller, T., Schwartz, A., Storch, A., & Winner, B. (2000) · Journal of Neurology · doi:10.1007/pl00007774 · Cited by 5

Phase I Randomized, Placebo-Controlled, Cross-Over Dose-Finding Study of Coenzyme Q10 on Doxorubicin Pharmacokinetics during Breast Cancer Treatment

Greenlee, H., Crew, K. D., Maurer, M., Kalinsky, K. M., Cremers, S., Naini, A., Tsai, W. Y., Shi, Z., Brogan, F., & Hershman, D. L. (2025) · Integrative Cancer Therapies · doi:10.1177/15347354251388014 · Cited by 4

Therapeutic strategies in Huntington?s disease

Alberch, J., Canals, J. M., & Pérez‐Navarro, E. (2003) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.13.4.449 · Cited by 4

Investigational drugs for the management of Huntington’s disease: are we there yet?

Kulkarni, P., & Saxena, U. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.934807 · Cited by 4

Non-Herbal Nutritional Supplements—The Next Wave: A Comprehensive Review of Risks and Benefits for the C-L Psychiatrist

Crone, C. C., Gabriel, G., & Wise, T. N. (2001) · Psychosomatics · doi:10.1176/appi.psy.42.4.285 · Cited by 4

Combination Supplement Therapy: A New Frontier in Treatment of Neurodegenerative Diseases

Shtilbans, A. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.07.004 · Cited by 3

Coenzyme Q10 as an antioxidant in the elderly

Yubero‐Serrano, E. M., Gutierrez-Mariscal, F. M., García‐Ríos, A., Delgado‐Lista, J., Pérez‐Martínez, P., Camargo, A., Pérez‐Jiménez, F., & López‐Miranda, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818698-5.00016-x · Cited by 3

New Techniques for Understanding Huntington's Disease

Hurley, R. A., Jackson, E. F., Fisher, R. E., & Taber, K. H. (1999) · Journal of Neuropsychiatry · doi:10.1176/jnp.11.2.173 · Cited by 3

Huntington’s Disease: Clinical Experimental Therapeutics

Ray, D. E., & Shoulson, I. (2011) · Cited by 3

Naturally occurring neuroprotectants in glaucoma

Patel, R. P., Shamsher, E., Hill, D., & Cordeiro, M. F. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.06.022 · Cited by 3

Espectroscopia cuantitativa de hidrógeno por resonancia magnética de 3 T en pacientes sintomáticos y asintomáticos con enfermedad de Huntington

Alcauter, S., Pasaye, E. H., Alvarado-Alanis, P., Delgado, R. O. F., Vilatela, M. E. A., Lujambio, P. S., & Barrios, F. A. (2010) · Revista de Neurología · doi:10.33588/rn.5104.2009173 · Cited by 3

Huntington’s Disease

Labadorf, A. T., Hoss, A. G., & Myers, R. H. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_33 · Cited by 3

Energy Metabolism in Huntington’s Disease

Fabola, M., Dobránsky, T., Gervsio-Carvalho, E. A. D., Jader, S., & Fernando, A. (2012) · InTech eBooks · doi:10.5772/31610 · Cited by 3

Huntington's disease

Kosinski, C. M., & Landwehrmeyer, G. B. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.058 · Cited by 3

Imaging in Huntington’s Disease and Other Choreas

McGarry, A. J., & Biglan, K. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-471-5_13 · Cited by 3

The effect of coenzyme Q10 on endothelial function in a young population

PETROFSKY, J. S., Laymon, M. S., Lee, H., Hernández, E., Dequine, D., Thorsen, L., Lovell, R. R. H., & de Andrade, J. N. B. M. (2012) · Physical therapy rehabilitation science · Cited by 3

Coenzyme Q10 as an Antioxidant in the Elderly

Yubero‐Serrano, E. M., García‐Ríos, A., Delgado‐Lista, J., Pérez‐Martínez, P., Camargo, A., Pérez‐Jiménez, F., & López‐Miranda, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405933-7.00011-1 · Cited by 3

Huntington’s Disease and Dementia

Estrada‐Sánchez, A. M., Bunner, K. D., & Rebec, G. V. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00008-2 · Cited by 3

HUNTINGTON DISEASE: CURRENT ADVANCES IN PATHOGENESIS AND RECENT THERAPEUTIC STRATEGIES

Wani, T. A., Al-Omara, M. A., & Zargar, S. (2011) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2011.030201 · Cited by 3

Chapter 5 Mitochondrial Abnormalities in Neurodegenerative Disorders

Tabrizi, S. J., & Schapira, A. H. V. (2002) · Blue books of practical neurology · doi:10.1016/s1877-3419(09)70064-9 · Cited by 3

Neuroprotection becomes reality: changing times for cerebral resuscitation.

Damian, M. S. (2004) · PubMed · Cited by 3

Imaging Biomarkers in Huntington’s Disease

de Natale, E. R., Wilson, H., & Politis, M. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_19 · Cited by 2

Magnetic Resonance Spectroscopy: Clinical Applications

Horská, A., Berrington, A., Barker, P. B., & Tkáč, I. (2023) · Springer eBooks · doi:10.1007/978-3-031-10909-6_10 · Cited by 2

Mechanism and Clinical Application Prospects of Mitochondrial DNA Single Nucleotide Polymorphism in Neurodegenerative Diseases

Xu, M., Li, T., Liu, X., Islam, B., Xiang, Y., Zou, X., & Wang, J. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04311-9 · Cited by 2

Oxidative stress modulation in neurodegenerative diseases

Carlesi, C., Ienco, E. C., Piazza, S., Gerfo, A. L., Alessi, R., Pasquali, L., & Siciliano, G. (2011) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1007/s12349-011-0053-z · Cited by 2

Peripheral and cerebral metabolic features in an animal model of Huntington's disease

Lopes, C., Duarte, A. I., Hayden, M. R., & Rego, A. C. (2012) · IEEE Portuguese Meeting on Bioengineering · doi:10.1109/enbeng.2012.6331390 · Cited by 2

Coenzyme q10: koenzim q10

GÜRKAN, A. S., & Dündar, O. B. (2005) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.1501/eczfak_0000000022 · Cited by 2

Magnetic Resonance Spectroscopy: Clinical Applications

Horská, A., & Tkáč, I. (2011) · Springer eBooks · doi:10.1007/978-1-4419-0345-7_9 · Cited by 2

Moderate Intensity Exercise in Pre-manifest Huntington's Disease: Results of a 6 months Trial.

Aldine, A. S., Ogilvie, A. C., Wemmie, J. A., Kent, J. D., Schultz, J. L., Long, J. D., Kamholz, J. A., Sajjad, H., Kline, J. N., Shaw, E. E., et al. (2021) · PubMed · Cited by 2

Mitochondrial Approaches to Neuroprotection

Beal, M. F. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06274-6_4 · Cited by 2

Huntington disease

Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00014-7 · Cited by 2

Behavioral, Electrophysiological, and Biochemical Consequences of Chronic Cytochrome Oxidase Inhibition in Rats

Bennett, M. C., & Rose, G. M. (1998) · Springer eBooks · doi:10.1007/978-1-4757-9936-1_8 · Cited by 2

Therapeutics in Huntington’s Disease

Rosas, H. D., & Koroshetz, W. J. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06274-6_17 · Cited by 2

Clinical Manifestations and Mechanisms of Action of Environmental Mitochondrial Toxins

Sabri, M. I., Spencer, P. S., Baggia, S., & Ludolph, A. C. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-692-8_1 · Cited by 2

Biochemical and Pharmacological Properties of Coenzyme Q Analogs

Mordente, A., Martorana, G. E., Giardina, B., Meucci, E., & Minotti, G. (2000) · Modern nutrition · doi:10.1201/9781420036701.ch10 · Cited by 2

Systemic Administration of 3-Nitropropionic Acid

Brouillet, E., Hantraye, P., & Beal, M. F. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-691-1_16 · Cited by 2

Neuroprotection Becomes Reality

Damian, M. S. (2004) · Advances in experimental medicine and biology · doi:10.1007/978-0-306-48526-8_12 · Cited by 2

Mitochondrial Dysfunction and Neurodegenerative Diseases

Lin, M., & Beal, M. F. (1998) · Springer eBooks · doi:10.1007/978-3-662-12509-0_13 · Cited by 1

REVIEW ARTICLE Mechanisms of neurodegeneration in Huntington's disease

Gil‐Mohapel, J., & Rego, A. C. (2008) · Cited by 1

Validation of Dementia Models Employing Neuroimaging Techniques

Vanhoutte, G., Campo, A., & der Linden, A. V. (2010) · Neuromethods · doi:10.1007/978-1-60761-898-0_11 · Cited by 1

Replicating Huntington Disease’s Phenotype in Nonhuman Primates

Hantraye, P., Palfi, S., Mittoux, V., Dautry, C., Condé, F., & Brouillet, E. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-691-1_17 · Cited by 1

Mitochondrial Dysfunction in Brain and Muscle Pathology of Huntington’s Disease

Rivera, S., McMurray, C. T., & Ayala‐Peña, S. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_133 · Cited by 1

Huntington disease

Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00013-5 · Cited by 1

Autophagy as a Neuroprotective Mechanism Against 3-Nitropropionic Acid-Induced Cell Death

Galindo, M. F., Sáez-Atiénzar, S., Bonet‐Ponce, L., & Jordán, J. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13939-5_8 · Cited by 1

Treatment Paradigms in Huntington’s Disease

Kulkarni, P., & Saxena, U. (2018) · Springer eBooks · doi:10.1007/978-981-13-0944-1_17 · Cited by 1

Magnetic resonance spectroscopy of neurodegenerative illness

Jenkins, B. G., Choi, J., & Beal, M. F. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.022 · Cited by 1

Chapter 7 Current and Future Prospects for the Treatment of Mitochondrial Disorders

Taylor, R. W., & Turnbull, D. M. (2002) · Blue books of practical neurology · doi:10.1016/s1877-3419(09)70066-2 · Cited by 1

A Gain of Function of the Huntington’s Disease and Amyotrophic Lateral Sclerosis-Associated Genetic Mutations May Be a Loss of Bioenergetics

Beal, M. F. (2001) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-04399-8_13 · Cited by 1

Disease Modifying Agents for Huntington??s Disease

Clarke, H., & Feigin, A. (1999) · CNS Drugs · doi:10.2165/00023210-199912050-00005 · Cited by 1

Opportunities and Challenges of the Therapies Targeting CNS Regeneration

Perez, H. D., Mitrovic, B., & Evercooren, A. B. (2005) · Springer eBooks · doi:10.1007/3-540-27626-2 · Cited by 1

Clinical Applications

Weir, J. P. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-573-2_6 · Cited by 1

Increased activity of surviving locus ceruleus neurons in Alzheimer's disease

Moser (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199901)45:1

The molecular pathogenesis of Huntington’s disease

Turner, C. D. (2009) · UCL Discovery (University College London)

Peripheral and cerebral metabolic features in an animal model of huntington's disease expressing full-length mutant huntingtin

Lopes, C. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)

Chapter 10 Hyperkinetic Movement Disorders

Hristova, A. H., & Koller, W. C. (2001) · Blue books of practical neurology · doi:10.1016/s1877-3419(09)70017-0

Physiological MR in neurodegenerative diseases

Martin, W. R. W. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9781139193481.043

Characterization of in vitro and in vivo huntingtin proteolysis in Huntington's disease

Tebbenkamp, A. T. N. (2010) · University of Florida Digital Collections (University of Florida)

Disorders of the mitochondrial respiratory chain

Schapira, A. H. V. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.063

Transfert de genes a potentiel therapeutique dans des modeles de la maladie de huntington developpes chez le rat

Bemelmans, A. (1999)

Mitochondrial dysfunction in diabetes mellitus

Anderson, C. M. (1999) · Drug Development Research · doi:10.1002/(sici)1098-2299(199901)46:1 · Cited by 18

Molecular Pathways of Mitochondrial Dysfunction in Neurodegeneration: the Paradigms of Parkinson's and Huntington's Diseases

Rego, A. C., Cardoso, S. M., & Oliveira, C. R. (2007) · Springer eBooks · doi:10.1007/978-0-387-70830-0_9 · Cited by 1

Coenzyme Q 10 – its biochemical and related aspects

Kopřiva, V., Dvořák, P., Pokorná, J., & Žďárský, M. (2015) · Acta Veterinaria Brno · doi:10.2754/avb201585010043

KATERE SO PRILAGODITVENE REAKCIJE NA TELESNO

Eiken, O. (2008)

Coenzyme Q10 and Behavior in Huntington’s Disease

Hickey, M. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00091-4

Eine epidemiologische Studie im süddeutschen Raum

Rehm, M. M. (2004)

MRS in neurodegenerative disease

Barker, P. B., Bizzi, A., Stefano, N. D., Gullapalli, R. P., & Lin, D. D. M. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511770647.010

Huntington's Disease: Unraveling the Pathophysiological Cascade Behind a Singular Gene Defect

Kosinski, C. M., Landwehrmeyer, G. B., & Ludolph, A. G. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_11

Role of Mitochondria in Parkinson’s Disease and Huntington’s Disease

Schapira, A. H. V. (2012) · Oxidative stress and disease · doi:10.1201/b12308-23

Oxidative Stress and Huntington’s Disease

Turner, C., & Schapira, A. H. V. (2003) · Oxidative stress and disease · doi:10.1201/9780203912874.ch20

Innovative approaches to monitor mutant huntingtin and to facilitate its degradation in Huntington's disease models

Fakultät, P.-N. (2011)

Is mitochondrial oxidative metabolism the right therapy target in early Huntington disease?

Lodi, R. (2016) · Neurology · doi:10.1212/wnl.0000000000003497

The effect of mitochondrial toxins on cytochrome c oxidase subunit IV isoforms and its consequences on mitochondrial function and neural cell survival

Misiak, M., & Arnold, S. (2010) · RWTH Publications (RWTH Aachen)

Cytochrome c oxidase mediates the regulation of mitochondrial function in an in vitro model of Huntington's disease

Singh, S., & Wagner, H. N. (2009) · RWTH Publications (RWTH Aachen)

Role of autophagy in GM1-mediated neuroprotection in Huntington's Disease

Schmelz, S. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3sj1b59m

Inherited Neurodegenerative Disorders

Sumathipala, D., & Dissanayake, V. H. W. (2018) · Springer eBooks · doi:10.1007/978-981-13-0944-1_7

Huntington's Disease

Browne, S. E., & Beal, M. F. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50051-2

Effects of Coenzyme Q10 Supplementation on Elderly People

Yubero‐Serrano, E. M., Gutierrez-Mariscal, F. M., & López‐Miranda, J. (2020) · Springer eBooks · doi:10.1007/978-3-030-45642-9_17

Novel nutraceuticals to tackle brain and muscle bioenergetics

Ostojić, S. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819621-2.00019-x

Imaging of Cerebral Metabolism in Huntington’s Disease

Kuwert, T. (2003) · Springer eBooks · doi:10.1007/978-3-642-55539-8_19

The paradigm of Huntington’s disease: Therapeutic opportunities in neurodegeneration

Leegwater‐Kim, J., & Cha, J.-H. J. (2004) · Neurotherapeutics · doi:10.1007/bf03206573

Epilepsy

Morello, G. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-2333-5.00163-2

Epilepsy

Morello, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-43044-9.00167-9

Oxidative stress modulation in neurodegenerative diseases

Carlesi, C., Ienco, E. C., Piazza, S., Gerfo, A. L., Alessi, R., Pasquali, L., & Siciliano, G. (2011) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1007/s12349-011-0055-x

Enfermedad de Huntington: Un abordaje desde lo celular y lo fisiológico

Avella, N., Rubio, C. F. G., Suárez, M. A. C., Ortiz, S. A., & Abreu, S. F. (2022) · Revista Salud Bosque · doi:10.18270/rsb.4585

Restoration of Enzymatic Activity of Energy-Related Proteins in Rats with Traumatic Brain Injury Following Administration of Gamma-Glutamylcysteine Ethyl Ester

Rice, B., Overbay, J., Sebastian, A. H., Sullivan, P. G., & Reed, T. T. (2025) · Brain Sciences · doi:10.3390/brainsci15101067

The clinical utility of multidisciplinary rehabilitation in individuals with Huntington’s Disease

Cruickshank, T. M. (2015) · Australasian Journal of Paramedicine

Étude de l'implication potentielle des marqueurs du striatum dans la maladie de Huntington

Galvan, L. (2011) · theses.fr (ABES) · doi:10.70675/ebf9c275z3ce2z474dz8d5az68c2c35df509

Développement de l’imagerie métabolique par IRM-CEST : application à la maladie de Huntington

Pépin, J. (2018) · theses.fr (ABES) · doi:10.70675/36f26e42z6133z47dbz84a3z07fae7850aa0

Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington's disease

Kašparová, S., Sumbalová, Z., Bystrický, P., Kucharská, J., Liptaj, T., Mlynárik, V., & Gvozdjáková, A. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.09.002 · Cited by 65

Evidence for irnnairment of energy metabofism in vivo in Huntington's disease using localized 1H NMR spectroscopy

Jenkins, B. G., Koroshetz, W. J., Beal, M. F., & Rosen, B. R. (1993) · Neurology · doi:10.1212/wnl.43.12.2689 · Cited by 479

Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice

Smith, K. M., Matson, S., Matson, W. R., Cormier, K., Del Signore, S. J., Hagerty, S. W., Stack, E. C., Ryu, H., & Ferrante, R. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.03.004 · Cited by 127

A Gain of Function of the Huntington’s Disease and Amyotrophic Lateral Sclerosis-Associated Genetic Mutations May Be a Loss of Bioenergetics

Beal, M. F. (2001) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-04399-8_13 · Cited by 1

Coenzyme Q10 serum levels in Huntington’s disease

Andrich, J., Carsten Saft, C., Gerlach, M., Schneider, B., Arz, A., Kuhn, W., & Müller, T. (2004) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-0579-5_13 · Cited by 31